Cultured primary human cells have been widely used to assess the selectivity of oncolytic viruses as potential anticancer agents. As culture conditions can potentially have a significant impact on virus replication and ultimately cell killing, we evaluated the effects of dl309, a wild-type adenovirus, and dl01/07, a conditionally replicating adenovirus mutant, on quiescent and proliferating primary mammary epithelial cells. When primary cells were induced into quiescence, both viruses exhibited similar attenuated cell killing. However, cell killing by dl309 was superior to dl01/07 in proliferating primary cells. Analysis of viral effects at the level of entry, E2F activation, DNA replication, and late gene expression indicated that attenuation of dl309 in quiescent cells correlated with decreased expression of viral late genes such as hexon. In contrast, attenuation of dl01/07 in quiescent cells correlated with inefficient induction of E2F activity and inability to undergo efficient DNA replication. In proliferating cells, dl309 replicated efficiently, whereas dl01/07 still showed attenuated replication. In summary, our results indicate the intrinsic preference of wildtype adenoviruses for killing proliferating cells, which is an attractive feature for using adenoviruses as oncolytic agents. These results also highlight the need for the use of appropriate growth conditions for primary cells in vitro to distinguish subtle differences in cell killing among various oncolytic viruses. Cancer Gene Therapy (2005) 1,2 Based on their ability to selectively kill tumor cells in cell culture and antitumor activity in xenograft tumor models, a few of these engineered viruses are currently being evaluated as oncolytic agents in the clinic. As human adenoviruses do not replicate well in nonhuman cells, it has not been possible to study toxicity related to replication in nontarget tissues in preclinical animal models. In the absence of suitable in vivo models, analysis of selective replication is widely performed by studying these viruses for their effect in vitro on tumor cells lines and primary nontransformed cells. 4 The effect of oncolytic viruses in vitro has been determined at the level of viral DNA replication, late gene expression, induction of cell death, and production of progeny virion. 5 In the in vitro assays, whether cells are rapidly growing or arrested can potentially have a significant effect on virus replication and ultimately cell killing.
R eplication-competent adenoviruses are currently being evaluated as novel anticancer agents. A number of modifications in the genome of the adenovirus have been reported to result in viruses that are capable of selectively replicating in and killing cancer cells. 1, 2 Based on their ability to selectively kill tumor cells in cell culture and antitumor activity in xenograft tumor models, a few of these engineered viruses are currently being evaluated as oncolytic agents in the clinic. 3 As human adenoviruses do not replicate well in nonhuman cells, it has not been possible to study toxicity related to replication in nontarget tissues in preclinical animal models. In the absence of suitable in vivo models, analysis of selective replication is widely performed by studying these viruses for their effect in vitro on tumor cells lines and primary nontransformed cells. 4 The effect of oncolytic viruses in vitro has been determined at the level of viral DNA replication, late gene expression, induction of cell death, and production of progeny virion. 5 In the in vitro assays, whether cells are rapidly growing or arrested can potentially have a significant effect on virus replication and ultimately cell killing.
In the present study, we sought to compare the effect of the wild-type adenovirus and a mutant that was previously reported to replicate preferentially in tumor cells for their effects in proliferating and quiescent normal cells. Our results show that in vitro, replication competent adenoviruses including wild type are highly attenuated in primary cells that are quiescent. In contrast, wild-type virus replicates efficiently in proliferating normal cells. Measurement of their effects at the level of entry, DNA replication, and late gene expression indicate that DNA replication of the wild-type virus was not substantially altered in quiescent cells. However, decreased expression of viral late genes such as hexon correlated with attenuation of the wild-type virus in quiescent cells.
Materials and methods

Viruses
The following viruses were used in the study. dl309 is a phenotypically wild-type adenovirus with deletions in E3 region.
6 dl01/07 contains the same deletion in E3 region as dl309 and two additional deletions in E1a between amino acids 4-25 and between amino acids 111-123, which abolishes binding of E1a to p300 and retinoblastoma protein. Owing to deletions in E1a, dl01/07 has been shown to be selectively attenuated in normal cells.
1 rAd-GFP is an E1-deleted adenoviral vector encoding GFP. 7 Viruses were grown on A549 cells, purified by HPLC, 8 and concentrations determined in particles/ml upon elution from a Resource Q anion exchange HPLC. 9 
Cell culture
Normal human mammary epithelial cells (HMECs) were obtained from Clonetics, a division of Cambrex (San Diego, CA) and maintained in their specific growth medium (Clonetics, San Diego, CA) at low passage. To induce quiescence, low passage cells were cultured in growth medium until 50% confluent. The medium was then removed and replaced with basal medium for 2 days. Reduced proliferation in the quiescent population was confirmed by bromodeoxyuridine labeling. 10 
Cell viability assay
The cells were seeded into 96-well plates at 2.5 Â 10 3 or 5 Â 10 3 cells/well and incubated for 24 hours. To induce quiescence, growth medium in the high cell density plates was changed to basal medium that lacks supplemented growth factors and incubated for 2 additional days. Cells plated at low density (2.5 Â 10 3 cells/well) were incubated for 2 days in growth medium and treated as proliferating cells. The adenovirus was serially diluted and added to the cells. After incubating for 1 hour at 371C, the virus was removed by aspiration and the cells fed with either 200 ml growth or basal medium. The 96-well plates were then incubated in a CO 2 incubator at 371C for 5 days. At the end of the incubation period, 40 ml of MTT reagent (Promega, Madison, WI) was added to the wells and the plates were incubated for an additional 1-4 hours at 371C. The absorbance was read using a SpectraMax 250 plate reader (Molecular Devices, Sunnyvale, CA) at 490 nm. The values of the treated wells were calculated as a percent of untreated control and represent triplicate samples of each dilution.
Measurement of adenovirus transduction efficiency
Quiescent or proliferating cells grown in six-well plates were infected with rAd-GFP at concentrations ranging from 1 Â 10 5 particles/ml-1 Â 10 9 particles/ml for 1 hour. After incubation, the cells were washed with PBS, and the medium added back to the cells. After 24 hours, the cells were removed by trypsinization and subjected to fluorescence-activating cell sorting (FACS) (Becton Dickinson, San Diego, CA).
Analysis of cell surface expression of coxsackie and adenovirus receptor (CAR) and integrins
To assay for CAR expression, cells were trypsinized and incubated with CAR antibody (RMCB, IgG1) followed by incubation with goat anti-mouse FITC-conjugated secondary antibody (Chemicon, Temecula, CA). To determine expression of integrins, cells were incubated with primary antibodies to b1, avb3, and avb5 integrins (Chemicon) followed by incubation with goat anti-mouse FITC-conjugated secondary antibody (Chemicon). After incubation with antibodies, cells were subjected to FACS.
Reporter assay for E2F
A total of 6.2 Â 10 4 cells seeded in each well of a 24-well tissue culture plate were transfected with 0.375 mg E2F-reporter plasmid containing adenoviral E2a promoter upstream of luciferase cDNA 2 or a control luciferase vector without a promoter (pGL3-basic from Promega, Madison, WI) and 0.125 mg b-galactosidase plasmid (pCMV-b from Invitrogen, Carlsbad, CA) for each well using Superfect (Qiagen, Valencia, CA) according to the manufacturer's instructions. Luciferase activities were determined 48 hours later using a commercially available kit (Promega) and the Analyst AD (Molecular Devices, Sunnyvale, CA). After measuring the luciferase activity in various cell lysates, relative activity was expressed as the fold increase over the activity obtained with pGL3-basic.
Detection of replicating adenoviral DNA
Cells were infected with adenovirus, harvested at multiple time points, and the viral DNA was isolated by Hirt extraction. Briefly, the cell pellet was lysed in a buffer containing 10 mM Tris, 10 mM EDTA, and 0.6% SDS. NaCl (5 M) was added to the lysate and the solution incubated at À201C. After centrifugation, the supernatants were treated with proteinase K for 1 hour, phenol chloroform-chloroform extracted, and precipitated with ethanol. Viral DNA was then digested with EcoRV and subjected to electrophoresis on a 1% agarose gel. Adenovirus DNA bands were visualized on the AlphaImager (Alpha Innotech Corporation, San Leandro, CA) after staining the gel with ethidium bromide.
Real-time quantitative PCR assay
Real-time quantitative PCR and RT-PCR assays were performed as described in detail in a previous paper. 11 Briefly, cells were harvested at various time points, pelleted, and frozen at À701C. DNA was prepared following lysis of the pellets with reagents from the QIAamp DNA mini kit (Qiagen, Valencia, CA). PCR reactions were performed with sample DNA and specific adenovirus hexon sequence primer pairs plus a target sequence-specific oligonucleotide probe labeled with a reporter fluorescent dye at the 5 0 -end and a quencher fluorescent dye at the 3 0 -end. The reaction was monitored in real time during PCR amplification using the 7700 Sequence Detector (Perkin-Elmer Applied BioSystems, Foster City, CA).
Detection of hexon protein
Infected cells were harvested at multiple time points, resuspended in PBS, and fixed with 2 volumes of cold methanol by incubating at À201C for 30 min. The cell suspension was then washed with PBS containing 2% FCS and resuspended in PBS containing anti-hexon monoclonal antibody conjugated to FITC (Chemicon, Temecula, CA), and incubated at 41C for 1 hour, and subjected to FACS.
Results
Inefficient killing of quiescent cells by adenoviruses
To study the effects of adenoviruses on quiescent and proliferating primary cells, HMECs were induced into quiescence through the removal of growth factors or maintained as a proliferating population in normal growth medium at subconfluent densities. As most human tumors are of epithelial origin, primary epithelial cells were chosen for the analysis. Selection of primary epithelial cells was based on previous observations indicating poor infectivity and delayed cytopathic effect in fibroblasts and endothelial cells. 5 Induction of quiescence in primary epithelial cells was confirmed by performing BrdU incorporation assays. The quiescent cells incorporated BrdU less efficiently when compared to proliferating cells (29% compared to 58%) (Fig 1) . Induction of quiescence was further confirmed by cell cycle analysis of propidium iodide-stained cells, which revealed an increase in the percentage of quiescent cells in G0/G1 and a nine-fold reduction of cells in the S phase compared to proliferating cells. Both quiescent and proliferating cells were infected with dl309 and dl01/07. Cytopathic effects and cell killing were assessed 5 days postinfection by visual assessment and MTT assay, which measures metabolic activity. We have observed a reduction in cellular p53 activity after extended time of primary cells in culture (unpublished observation). Owing to the possibility of deleterious effects on these primary cells upon long-term culture (45 days), we decided to perform analysis at or prior to 5 days postinfection. As shown in Figure 2 , compared to their effects in proliferating cells, both dl309 and dl01/07 were attenuated similarly in quiescent primary HMECs. The ED 50 of dl309 in quiescent cells is 2 Â 10 8 particles/ml, while the ED 50 in proliferating cells is o3 Â 10 6 particles/ml, a difference of approximately 2 logs. The ED 50 of dl01/07 in quiescent cells is 2 Â 10 8 particles/ml, while the ED 50 in proliferating cells is 5 Â 10 7 particles/ml (Fig 2) . 
Induction of quiescence does not alter CAR and integrin expression
To determine whether the attenuated effect of both dl309 and dl01/07 in quiescent cells is due to a reduction in the expression of CAR and integrin, cellular receptors for adenovirus binding and entry, expression of CAR and integrins was determined by FACS. However, no major changes in CAR expression was detected (Fig 3) . Analysis of integrins revealed that avb3 integrins could not be detected, while avb5 integrins were expressed but unchanged between quiescent and proliferating cells (Fig 4a and b) . The expression of b1 integrin, a cell adhesion marker, also appears to be unchanged between quiescent and proliferating HMECs, indicating that the cells maintain functional adherence (Fig 4c) . These findings suggest that quiescent and proliferating HMECs are capable of binding and internalizing adenovirus.
Induction of quiescence does not substantially alter transduction efficiency in HMEC
To examine the ability of HMECs cultured under different growth conditions to become transduced and express a transgene, quiescent and proliferating cells were treated for one hour with serial dilutions of rAd-GFP. After a 24 hour incubation, the cells were sorted by FACS. The quiescent population of cells exhibited reduced fluorescence as compared to the proliferating population infected with the same dose. The graph compares the number of GFP-positive cells detected as a function of rAd-GFP concentration in particles/ml. The particle concentration needed to achieve 50% of cells positive for GFP expression 4.7 Â 10 8 particles/ml for the quiescent cells as compared to 1.4 Â 10 8 particles/ml for the proliferating cells (Fig 5) , indicating that transduction-translation efficiency is reduced but not substantially altered when cells are in quiescence.
dl309, but not dl01/07, efficiently activates E2F upon infection of quiescent cells
As the transcription factor E2F is essential for the induction of S phase as well as expression of viral DNA replication proteins, we measured E2F activity in quiescent and proliferating cells upon infection with viruses using an E2F-luciferase reporter. HMECs were transfected with the E2F-reporter plasmid and then infected with dl309 or dl01/07. Infection of both quiescent and proliferating cells with dl309-stimulated E2F activity by 97-and 57-fold, respectively, whereas infection of both quiescent and proliferating cells with dl01/07 resulted in reduced stimulation of E2F activity (26-and 10-fold) (Fig 6) .
DNA replication is not reduced in quiescent cells infected with dl309
After infection with dl309 or dl01/07, HMECs were harvested at multiple time points for DNA isolation. Increased viral DNA from dl309-infected quiescent HMECs was observed after quantitative PCR analysis for viral genome. At 72 hours, a two-fold increase in viral DNA was detected in cells maintained in basal medium compared to cells cultured in growth medium after normalizing DNA in the two populations to a b-actin control (Fig 7a) . In contrast to DNA replication of dl309, DNA replication of dl01/07 was attenuated in both quiescent and proliferating cells at 72 hours (Fig 7a) . Robust DNA replication of dl309 in quiescent cells was also confirmed by Hirt DNA analysis (Fig 7b) . These results, together with data shown in Figure 6 , suggest that although both dl309 and dl01/07 are similarly attenuated in quiescent cells, attenuation of dl01/07, but not dl309, is due to failure of dl01/07 to activate efficiently E2F and undergo DNA replication.
Greatly reduced hexon expression in quiescent cells infected with dl309
To understand the potential causes for greater attenuation of dl309 in quiescent cells, expression of hexon, a late viral gene product, was determined by FACS following infection of quiescent or proliferating cells with dl309 at multiple time points. Proliferating cells infected with dl309 and harvested on day 3 displayed a mean fluorescence of 344.5726.4, while quiescent infected cells had a mean fluorescence of 172.7716.7 (data not shown) with about two-fold increase in hexon-positive cells when cells are proliferating (Fig 8a) . In contrast, when HMECs were infected with dl01/07, virtually no hexon-positive cells were detected 3 days post-infection in either quiescent or proliferating population (Fig 8a) . Even Figure 3 Expression of known adenovirus receptor, CAR, is not altered in quiescent cells. Cells were treated with anti-CAR monoclonal antibody followed by incubation with FITC-conjugated anti-mouse antibody, and subjected to FACS.
Analysis of oncolytic adenoviruses
MT Vaillancourt et al at 6 days post-infection, expression of hexon from dl309 was greatly reduced in quiescent but not in proliferating cells (Fig 8b) , suggesting that reduced late gene expression is contributing to greater attenuation of dl309 in quiescent cells. This finding was confirmed by real-time RT-PCR analysis using primers for hexon. A six-fold decrease in hexon RNA was observed in quiescent cells infected with dl309 compared to infected proliferating cells.
Discussion
In the present study, we examined the effects of dl309, a wild-type adenovirus, and dl01/07, a mutant that was previously shown to be selectively attenuated in normal cells, for their effects on quiescent or proliferating normal cells. Our data show that dl309 is greatly attenuated (by 42-log) and exhibited cell killing similar to that of dl01/07 in quiescent normal cells. However, dl309, but not dl01/07, exhibited potent cell killing activity in proliferating normal cells. Similar levels of cell surface expression of CAR and integrins, receptors involved in viral binding and entry, suggest that greater attenuation of both viruses in quiescent cells is not likely due to alterations in virus binding and entry. Infection of quiescent cells with dl309, but not with dl01/07, resulted in efficient E2F activation and viral DNA replication. These results indicate that attenuation of dl01/07 in quiescent cells is due to the inability of dl01/07 to induce efficiently E2F and undergo DNA replication, whereas attenuation of dl309 in quiescent cells is not due to defects in viral DNA replication. However, expression of late viral protein, such as hexon, in dl309-infected cells was reduced when cells were induced into quiescence, indicating that a block or defect in the expression of late genes might result in greater attenuation of dl309 in quiescent cells. Our finding that indicates similar levels of attenuation of dl309 and dl01/07 in quiescent epithelial cells do not agree with the observation of Doronin et al. 12 This discrepancy could be due to the use of growth-arrested HEL 299, normal human diploid lung fibroblast by Doronin et al, instead of primary epithelial cells.
Although expression of CAR and integrins, the receptors involved in viral binding and entry, was not affected when cells were induced into quiescence, transduction efficiency as determined using a replicationdefective adenovirus encoding GFP was slightly reduced. This reduction in GFP expression could be the result of altered or blocked transcription from the CMV immediate-early promoter that drives the GFP cDNA. 13 Stimulation of infected quiescent cells with growth factors may induce transcription factors like NF-kB, which normally reside in the cytoplasm during quiescence to translocate to the nucleus to activate transcription of target genes. 14 dl01/07 was attenuated in both quiescent and proliferating normal cells, confirming previous findings.
1 Unlike dl309, dl01/07 is incapable of binding to p300 and retinoblastoma protein and fails to activate E2F. 1 Results from this study confirmed inefficient stimulation of E2F activity by dl01/07 in both quiescent and proliferating normal cells. Greater attenuation of dl01/07 in both quiescent and proliferating normal cells might be due to the failure of dl01/07 to induce efficiently E2F activity, which is essential for both stimulation of G1/S transition and expression of viral replication proteins. dl01/07 has been shown to replicate to near wild-type levels 1 in tumor cells, which is likely due to dysregulated E2F activity in tumor cells as a result of mutations in RB1 or CDKN2A, or overexpression of the CCND/CDK4 complex. 15 It was interesting to note that DNA replication of dl309 was not reduced in quiescent cells. Efficient DNA replication of dl309 in quiescent HMEC is likely due to induction of E2F activity. As viral DNA replication did not correlate with the attenuation of dl309 in quiescent cells, expression of viral late protein such as hexon was measured. Results indicated that expression of hexon was greatly reduced when cells were induced to quiescence, suggesting that activation of transcription from the major late promoter, which regulates late gene expression, may be altered in quiescent cells. Lack of optimum major late promoter activity, which controls most of the structural proteins, might in turn lead to reduced production of progeny virions. 16 In addition to the expression of viral structural proteins, expression of the adenoviral death protein (ADP), which plays an important role in killing of infected cells and virion release, is controlled by the major late promoter. ADP is expressed at low levels at early times in the lytic cycle, but synthesized in large amounts from mRNAs derived from the major late promoter. 17, 18 Therefore, a reduction in MLP activity as indicated by a reduction in hexon mRNA and protein expression could also affect killing of infected cells, thus leading to greater attenuation in quiescent cells. Additional studies are needed to understand the mechanism that leads to reduced late gene expression in quiescent cells.
Several studies have shown that dl309 is efficient in killing tumor cell lines irrespective of their genetic defects. 1, 2, 4 The greatly attenuated killing of quiescent cells compared to proliferating cells by dl309 observed in this study supports the notion 19 that adenoviruses that are not engineered as such may already be usable for cancer therapy. Based on differential replication in cancer cells versus nonproliferating normal cells, an E1a mutant adenovirus dl922-947 was also proposed to be a promising replication-selective virus for the treatment of cancer. 4 In light of the findings of this study, it is interesting to note that the potential therapeutic use of wild-type adenoviruses as oncolytic agents was recognized and tested in patients with cervical carcinoma in the early 1950s based on the observation that these viruses replicate efficiently and kill cultured HeLa cells. 20 Such therapies were not pursued aggressively possibly because of the variable responses due to limitations in technologies for the production and purification of viruses and the development of more active chemotherapeutic agents.
In vitro analysis of oncolytic viruses on normal cells is widely used to demonstrate the selectivity of oncolytic viruses. Our data demonstrate that the differences between dl309 and dl01/07 only in proliferating condition highlight the importance of using proper growth conditions to distinguish subtle differences among oncolytic viruses.
